Hill-Rom Holdings (Hill-Rom Holdings) Interest Expense : $-66 Mil (TTM As of Sep. 2021)

View and export this data going back to 1989. Start your Free Trial

What is Hill-Rom Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hill-Rom Holdings's interest expense for the three months ended in Sep. 2021 was $ -15 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2021 was $-66 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hill-Rom Holdings's Operating Income for the three months ended in Sep. 2021 was $ 121 Mil. Hill-Rom Holdings's Interest Expense for the three months ended in Sep. 2021 was $ -15 Mil. Hill-Rom Holdings's Interest Coverage for the quarter that ended in Sep. 2021 was 8.09. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hill-Rom Holdings Interest Expense Historical Data

The historical data trend for Hill-Rom Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hill-Rom Holdings Interest Expense Chart

Hill-Rom Holdings Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Interest Expense

Get a 7-Day Free Trial

-88.90

-95.00

-89.60

-74.00

-65.60

Hill-Rom Holdings Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Interest Expense	Get a 7-Day Free Trial															-18.20	-17.80	-17.10	-15.70	-15.00

Hill-Rom Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-66 Mil.

Hill-Rom Holdings (NYSE:HRC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hill-Rom Holdings's Interest Expense for the three months ended in Sep. 2021 was $-15 Mil. Its Operating Income for the three months ended in Sep. 2021 was $121 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2021 was $1,825 Mil.

Hill-Rom Holdings's Interest Coverage for the quarter that ended in Sep. 2021 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2021 )	/	Interest Expense (Q: Sep. 2021 )
	=	-1	*	121.4	/	-15
	=	8.09

The higher the ratio, the stronger the company's financial strength is.

Hill-Rom Holdings (Hill-Rom Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hill-Rom Holdings Inc (NYSE:HRC) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

130 East Randolph Street, Suite 1000, Chicago, IL, USA, 60601

Website

http://www.hill-rom.com

Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.

Executives

Mary Kay Ladone	officer: SVP, Corp. Dev., Strat. & IR	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Deborah Rasin	officer: SVP, Chief Legal Officer	TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601
Paul Sherwood Johnson	officer: SVP & Pres. - PSS Acute Care	TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601
Andreas G Frank	officer: SVP, Pres. Front Line Care	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner	officer: Corporate Controller	221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Amy M. Dodrill	officer: President - Surgical Solutions	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Gary Lee Ellis	director	THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420
Mary Garrett	director	ETHAN ALLEN DRIVE, DANBURY CT 06811
Gregory J. Moore	director	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
William Kucheman	director	C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447
James R Giertz	director
Ronald A Malone	director	3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747
Felicia F Norwood	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
William G Dempsey	director	C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425
Nancy M Schlichting	director	200 WILMOT ROAD, DEERFIELD IL 60015